Literature DB >> 12069838

Lysophosphatidic acid as an autocrine and paracrine mediator.

Yuhuan Xie1, Terra C Gibbs, Kathryn E Meier.   

Abstract

Recent studies have established that lysophosphatidic acid (LPA) is produced by a wide variety of cell types, and that most mammalian cells express receptors for LPA. These findings raise the hypothesis that LPA acts as an autocrine mediator to initiate signaling in the cells where it is produced, as well as a paracrine mediator to affect neighboring cells. The extent to which these scenarios occur will depend on the species of LPA generated, the LPA receptors expressed, and the ability of these receptors to bind to the LPA produced. The enzymes involved in LPA synthesis and their cellular localization in relationship to LPA receptors are also likely to be important. Studies addressing these issues with respect to the potential roles of LPA as an autocrine and paracrine mediator are reviewed, with examples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069838     DOI: 10.1016/s1388-1981(02)00181-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Effect of lysophosphatidic acid on the immune inflammatory response and the connexin 43 protein in myocardial infarction.

Authors:  Duoduo Zhang; Yan Zhang; Chunyan Zhao; Wenjie Zhang; Guoguang Shao; Hong Zhang
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

2.  Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.

Authors:  Chanygi Chen; Lyssa N Ochoa; Anna Kagan; Hong Chai; Zhengdong Liang; Peter H Lin; Qizhi Yao
Journal:  Atherosclerosis       Date:  2012-02-13       Impact factor: 5.162

3.  TRPM2 mediates the lysophosphatidic acid-induced neurite retraction in the developing brain.

Authors:  Yongwoo Jang; Mi Hyun Lee; Jesun Lee; Jooyoung Jung; Sung Hoon Lee; Dong-Jin Yang; Byung Woo Kim; Hyeon Son; Boyoon Lee; Sunghoe Chang; Yasuo Mori; Uhtaek Oh
Journal:  Pflugers Arch       Date:  2014-01-11       Impact factor: 3.657

4.  Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance.

Authors:  Myoung Sook Han; Yu-Mi Lim; Wenying Quan; Jung Ran Kim; Kun Wook Chung; Mira Kang; Sunshin Kim; Sun Young Park; Joong-Soo Han; Shin-Young Park; Hyae Gyeong Cheon; Sang Dal Rhee; Tae-Sik Park; Myung-Shik Lee
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

5.  Altered spatiotemporal expression of collagen types I, III, IV, and VI in Lpar3-deficient peri-implantation mouse uterus.

Authors:  Honglu Diao; John D Aplin; Shuo Xiao; Jerold Chun; Zuguo Li; Shiyou Chen; Xiaoqin Ye
Journal:  Biol Reprod       Date:  2010-09-23       Impact factor: 4.285

6.  Lack of stereospecificity in lysophosphatidic acid enantiomer-induced calcium mobilization in human erythroleukemia cells.

Authors:  Ulrika K Nilsson; Rolf G G Andersson; Johan Ekeroth; Elisabeth C Hallin; Peter Konradsson; Jan Lindberg; Samuel P S Svensson
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

7.  LPA Stimulates the Phosphorylation of p130Cas via Gαi2 in Ovarian Cancer Cells.

Authors:  Jeremy D Ward; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2012-09

8.  Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling.

Authors:  Xiaoqin Ye; Michael K Skinner; Grace Kennedy; Jerold Chun
Journal:  Biol Reprod       Date:  2008-04-30       Impact factor: 4.285

9.  Localization and translocation of RhoA protein in the human gastric cancer cell line SGC-7901.

Authors:  Yan Tao; Yong-Chang Chen; Yue-Ying Li; Shu-Qin Yang; Wen-Rong Xu
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 10.  Bioactive lysolipids in cancer and angiogenesis.

Authors:  Yu Hisano; Timothy Hla
Journal:  Pharmacol Ther       Date:  2018-07-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.